ADCT: ADC Therapeutics SA Stock

by  •  • Comments Off on ADCT: ADC Therapeutics SA Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 409.35
Enterprise Value ($M) 561.38
Book Value ($M) -148.25
Book Value / Share -1.80
Price / Book -2.76
NCAV ($M) -166.74
NCAV / Share -2.02
Price / NCAV -2.45

Profitability (mra)
Return on Invested Capital (ROIC) -0.82
Return on Assets (ROA) -0.51
Return on Equity (ROE) -6.37

Liquidity (mrq)
Quick Ratio 4.73
Current Ratio 4.97

Balance Sheet (mrq) ($M)
Current Assets 336.29
Assets 354.78
Liabilities 503.03
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 69.56
Operating Income -165.99
Net Income -240.05

Cash Flow Statement (mra) ($M)
Cash From Operations -118.69
Cash from Investing -3.22
Cash from Financing 73.88

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Redmile Group, LLC 18.80 13.00
02-13 13G/A Prosight Management, LP 8.00 50.35
02-12 13G/A Astrazeneca Plc 4.88 0.00
04-28 13D/A Auven Therapeutics Holdings Lp 7.90 0.00
2023-04-10 13G/A Fmr Llc 0.05 -99.13

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-13 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-18 53,364 278,551 19.16
2024-04-17 150,510 1,272,321 11.83
2024-04-16 43,806 238,230 18.39
2024-04-15 50,981 464,878 10.97

(click for more detail)

Similar Companies
ABBV – AbbVie Inc. ABT – Abbott Laboratories
ANRO – Alto Neuroscience, Inc. ANVS – Annovis Bio, Inc.


Financial data and stock pages provided by
Fintel.io